Latest S-1 registration statements

BestGofer Inc., a development stage company with no active business operations, files an amendment to its registration statement for a secondary offering of 2,080,000 common shares by selling shareholders at $0.04 per share.

Star Alliance International Corp. has filed an amendment to its registration statement, potentially allowing a selling stockholder to offer up to 75 million shares of common stock.

Livento Group aims to register up to 83.3 million shares of common stock for potential sale by selling stockholders, including shares issuable under an Equity Line Purchase Agreement and upon exercise of warrants.

Ibotta, Inc., a leading digital marketing platform, has filed for an initial public offering, seeking to expand its innovative Ibotta Performance Network (IPN) that connects consumer packaged goods (CPG) brands with over 200 million consumers.

PACS Group, a leading post-acute healthcare company, has filed an amendment to its S-1 registration statement for an initial public offering of 19,050,000 shares of common stock, with plans to list on the NYSE under the symbol PACS.

Allarity Therapeutics aims to raise up to $8 million through a best efforts offering of common stock, warrants, and pre-funded warrants to advance its stenoparib clinical trial and potentially repurchase Series A Preferred Stock.

New Horizon Aircraft Ltd. files an amendment to its S-1 registration statement, outlining potential sales of Class A ordinary shares and warrants by existing security holders, as well as the issuance of shares upon warrant exercises.

Aethlon Medical launches a best-efforts offering of common stock and warrants, aiming to raise capital for research, clinical trials, and general corporate purposes.

Aspira Women's Health is registering for resale up to 1,571,000 shares of its common stock, issuable upon the exercise of warrants previously issued in a private placement.

Longeveron Inc. is offering up to 2,461,538 shares of Class A common stock along with warrants to fund clinical trials and general corporate purposes.

Envirotech Vehicles is seeking to raise capital through an offering of common stock and pre-funded warrants.

Shuttle Pharmaceuticals Holdings, Inc. is launching a rights offering to raise up to $4.5 million to support its Shuttle Diagnostics subsidiary and for general corporate purposes.

Correlate Energy Corp. has filed an amendment to its registration statement for a proposed public offering of units, pre-funded units, and underlying common stock and warrants, contingent upon NYSE listing.

Envoy Medical seeks to register the issuance and resale of Class A Common Stock and warrants, potentially raising $203.4 million for general corporate purposes.

Cardiff Lexington Corporation files an amendment to its Form S-1/A registration statement, aiming to offer 1,600,000 shares of common stock and uplist to NYSE American under the symbol CDIX.

Ascent Solar Technologies aims to raise $6 million through a public offering of common stock and pre-funded warrants, with Dawson James Securities acting as the exclusive placement agent.

Skye Bioscience files an amendment to its S-1 registration statement to correct a scrivener's error in the auditor's report regarding the date of the original report.

bioAffinity Technologies is registering for the resale of up to 1.63 million shares of its common stock by selling stockholders after a recent $2.5 million private placement.

Shorepower Technologies aims to register the resale of 25,817,272 shares of common stock, including shares held by selling stockholders and those underlying warrants.

BestGofer Inc. has filed an amendment to its S-1 registration statement to register 2,080,000 shares of common stock for offering by selling shareholders.

Fly-E Group, an electric vehicle company, has filed Amendment No. 1 to its Form S-1 registration statement with the SEC for its proposed initial public offering of 3,000,000 shares of common stock.

Longeveron Inc. is offering up to 2,461,538 shares of Class A Common Stock along with warrants in a public offering to fund clinical trials and general corporate purposes.

Nascent Biotech aims to raise capital for Phase 2 clinical trials and administrative expenses through a self-underwritten public offering of 20,000,000 shares of common stock at $0.15 per share.

Artificial Intelligence Technology Solutions (AITX) has filed a registration statement for the resale of up to 2.5 billion common shares by GHS Investments, with the company potentially receiving up to $5.3 million from sales to GHS.

Venus Concept has filed a registration statement for the resale of up to 874,990 shares of its common stock by selling stockholders, which are issuable upon the exercise of outstanding warrants.

BioRestorative Therapies has filed a registration statement for the potential resale of up to 2,513,686 shares of its common stock by existing securityholders.

Ealixir Inc., an online reputation management company, files an S-1/A registration statement for a public offering, aiming to list its Common Stock on a national securities exchange and expand its services.

Calidi Biotherapeutics files an amendment to its Form S-1 registration statement to include updated exhibits and legal opinions related to its proposed offering.

Awaysis Capital, a real estate management and hospitality company, has filed an amendment to its Form S-1 registration statement for the resale of up to 60,031,866 shares of its common stock by selling shareholders.

Mustang Bio files an amendment to its S-1 registration statement to include exhibits related to securities purchase agreements and warrants.